Isabelle Lonjon‐Domanec
- Hepatology top 1%
- Hepatitis C virus research 36
- Liver Disease and Transplantation 3
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment 24
- Hepatitis B Virus Studies 18
-
- HIV/AIDS drug development and treatment 2
-
- Systemic Lupus Erythematosus Research 4
-
- Chronic Lymphocytic Leukemia Research 2
-
- Drug-Induced Hepatotoxicity and Protection 2
- Co-authors
- Ralph DeMasiMarc BourlièreGastón PicchioMagali Bouvier‐AliasTarik AsselahDenis OuzanHervé DesmoratJean–Pierre Bronowicki
- Partner nations
- FranceBelgiumUnited States
In The Last Decade
Isabelle Lonjon‐Domanec
37 papers receiving 586 citations
Peers
Comparison fields: 5 of 54
- Hepatology 541
- Epidemiology 522
- Infectious Diseases 79
- Rheumatology 48
- Genetics 22
Countries citing papers authored by Isabelle Lonjon‐Domanec
This map shows the geographic impact of Isabelle Lonjon‐Domanec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Lonjon‐Domanec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Lonjon‐Domanec more than expected).
Fields of papers citing papers by Isabelle Lonjon‐Domanec
This network shows the impact of papers produced by Isabelle Lonjon‐Domanec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Lonjon‐Domanec. The network helps show where Isabelle Lonjon‐Domanec may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Isabelle Lonjon‐Domanec, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 22 | |
| 2 | 2023 | 5 | |
| 3 | 2022 | 13 | |
| 4 | 2022 | 40 | |
| 5 | 2020 | 24 | |
| 6 | 2017 | 6 | |
| 7 | 2017 | 4 | |
| 8 | 2016 | 4 | |
| 9 | 2015 | 7 | |
| 10 | 2014 | 5 | |
| 11 | 2014 | 24 | |
| 12 | 2014 | 3 | |
| 13 | 2013 | 42 | |
| 14 | 2012 | 10 | |
| 15 | 2012 | 58 | |
| 16 | 2012 | 16 | |
| 17 | 2011 | 21 | |
| 18 | 2011 | 3 | |
| 19 | 2009 | 20 | |
| 20 | 2006 | 148 |
About Isabelle Lonjon‐Domanec
Isabelle Lonjon‐Domanec is a scholar working on Hepatology, Epidemiology and Pharmacology, having authored 37 papers that have together received 596 indexed citations. Recurring topics across this work include Hepatitis C virus research (36 papers), Liver Disease Diagnosis and Treatment (24 papers), Hepatitis B Virus Studies (18 papers), Systemic Lupus Erythematosus Research (4 papers), Liver Disease and Transplantation (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Drug-Induced Hepatotoxicity and Protection (2 papers) and HIV/AIDS drug development and treatment (2 papers). The work is most often cited by research in Hepatology (541 citations), Epidemiology (522 citations) and Infectious Diseases (79 citations). Isabelle Lonjon‐Domanec has collaborated with scholars based in France, Belgium and United States. Frequent co-authors include Ralph DeMasi, Marc Bourlière, Gastón Picchio, Magali Bouvier‐Alias, Tarik Asselah, Denis Ouzan, Hervé Desmorat, Jean–Pierre Bronowicki, Christophe Hézode and Jean‐Pierre Zarski. Their work appears in journals such as Journal of Hepatology, Digestive and Liver Disease, PLoS ONE, Liver International and Gut.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.